Literature DB >> 20109603

Diagnosis and management of cardiac sarcoidosis.

Simon W Dubrey1, Rodney H Falk.   

Abstract

Cardiac sarcoidosis is an underdiagnosed disease that may be present in as many as 25% of patients with systemic sarcoidosis. Although most commonly recognized in patients with other manifestations of sarcoidosis, it may occur in isolation and its presence is often not appreciated. Cardiac sarcoidosis may present as asymptomatic left ventricular dysfunction, congestive heart failure, atrioventricular block, atrial or ventricular arrhythmia and sudden death. Although untested in clinical trials, early use of high-dose steroid therapy may halt or reverse cardiac damage. This article reviews the clinical manifestations, diagnosis and treatment of sarcoidosis, with an emphasis on new imaging techniques and therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109603     DOI: 10.1016/j.pcad.2009.11.010

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  34 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping.

Authors:  Elliott D Crouser; Chikako Ono; Tam Tran; Xin He; Subha V Raman
Journal:  Am J Respir Crit Care Med       Date:  2014-01-01       Impact factor: 21.405

3.  Case Study: Cardiac sarcoidosis resolved with Mycobacterium avium paratuberculosis antibiotics (MAP).

Authors:  Branko G Celler
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

4.  A case of chest pain and heart failure.

Authors:  Emanuela Scannella; Laura Angaroni; Anna Coerezza; Monica Solbiati; Fabrizio Foieni; Nicola Montano
Journal:  Intern Emerg Med       Date:  2011-05-06       Impact factor: 3.397

5.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

6.  Diurnal characteristics of heart rate variability in patients with sarcoidosis.

Authors:  Z Aktop; H Tanrıverdi; F Uygur; A İşleyen; B Kalaycı; Y C Gursoy; T Karabağ; M Aydın; I Akpınar
Journal:  Herz       Date:  2016-10-13       Impact factor: 1.443

7.  Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis.

Authors:  Kursat Tigen; Murat Sunbul; Tansu Karaahmet; Onur Tasar; Cihan Dundar; Murat Yalcinsoy; Mumtaz Takir; Esen Akkaya
Journal:  Lung       Date:  2015-05-20       Impact factor: 2.584

8.  F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.

Authors:  Richard L Weinberg; Rachelle Morgenstern; Albert DeLuca; Jennifer Chen; Sabahat Bokhari
Journal:  J Nucl Cardiol       Date:  2016-05-19       Impact factor: 5.952

9.  Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Hiroshi Ohira; Keiichiro Yoshinaga; Takahiro Sato; Alisa Klaipetch; Noriko Oyama-Manabe; Yoichi M Ito; Ichizo Tsujino; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-29       Impact factor: 9.236

10.  [Differential diagnostic classification of ECG findings, incorporating cardiac MRI imaging].

Authors:  C Reithmann; B Herkommer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.